Canntab Therapeutics Ltd (PILL.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0050 unch (unch) 10/06/23 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.0050 unch (unch) -
Fiscal Year End Date: 05/31
(Values in thousands)
| 05-2022 | 05-2021 | 05-2020 | 05-2019 | 05-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 635 | 546 | 296 | 81 | 51 |
| Accounts receivable | -2 | -60 | 88 | -70 | -129 |
| Accounts payable and accrued liabilities | -202 | 207 | N/A | N/A | N/A |
| Other Working Capital | -182 | -647 | 131 | -317 | 108 |
| Other Operating Activity | -3,094 | -2,895 | -2,414 | -2,026 | -1,299 |
| Operating Cash Flow | $-2,846 | $-2,849 | $-1,899 | $-2,333 | $-1,269 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -272 | -805 | -250 | -106 |
| Purchase Sale Intangibles | -58 | -73 | -101 | -68 | -93 |
| Other Investing Activity | 239 | 0 | 1,175 | 2,325 | 0 |
| Investing Cash Flow | $151 | $-345 | $270 | $2,007 | $-199 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,300 | 1,492 | N/A | N/A | N/A |
| Debt Repayment | -64 | -79 | -65 | N/A | N/A |
| Common Stock Issued | 0 | 814 | 3,644 | 0 | 5,008 |
| Other Financing Activity | 659 | 368 | -272 | 22 | -281 |
| Financing Cash Flow | $1,895 | $2,595 | $3,306 | $22 | $4,727 |
| Beginning Cash Position | 1,491 | 2,090 | 414 | 718 | 959 |
| End Cash Position | 691 | 1,491 | 2,090 | 414 | 4,218 |
| Net Cash Flow | $-800 | $-600 | $1,676 | $-304 | $3,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,846 | -2,849 | -1,899 | -2,333 | -1,269 |
| Capital Expenditure | -88 | -345 | -905 | -318 | -199 |
| Free Cash Flow | -2,934 | -3,195 | -2,805 | -2,651 | -1,468 |